This is a quick video tour of one of the dedicated electrophysiology (EP) labs at the University of Colorado Hospital ...
This is the newest cardiac cath lab at the University of Colorado Hospital in Aurora, Colorado. Construction was ...
The U.S. Food and Drug Administration (FDA) has approved Portola Pharmaceuticals’ Prior Approval Supplement (PAS) for its large-scale, second generation Andexxa [coagulation factor Xa (recombinant), inactivated-zhzo], allowing for broad commercial launch in the United States.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Boston Scientific Corp. exercised its option to acquire the remaining shares of Millipede Inc, a privately-held company in Santa Rosa, Calif., upon its recent successful completion of a first-in-human clinical study. The acquisition will expand the Boston Scientific Structural Heart portfolio to include the Iris Transcatheter Annuloplasty Ring System, which is in development for the treatment of patients with severe mitral regurgitation (MR) who are not able to tolerate open-heart surgery.
Edwards Lifesciences Corp. announced that the Sapien 3 Ultra system has received U.S. Food and Drug Administration (FDA) approval for transcatheter aortic valve replacement (TAVR) in severe, symptomatic aortic stenosis patients who are determined to be at intermediate or greater risk of open-heart surgery.
Terrific Care LLC. / Medex Supply Dist Inc. initiated a nationwide recall on Dec. 19 of Roche CoaguChek test strips, as said products have been found to inaccurately report high INR test results. This recall only includes CoaguChek test strips distributed directly to U.S. consumers by Terrific Care LLC. / Medex Supply Dist Inc via its website/phone calls/facsimal of all catalog/REF numbers that do not end in 160.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
African-American men participating in a blood pressure reduction program implemented in barbershops continued to have significant improvements in their blood pressure in a twelve-month follow-up study. The research was published in the American Heart Association journal Circulation.
Patients who arrive at the hospital with heart-attack-like symptoms have had little recourse for their chest pain if scans came back clear, with no signs of blocked coronary arteries. Some of these cases are caused by a little-known phenomenon called coronary slow flow. Now, researchers at Jefferson (Philadelphia University + Thomas Jefferson University), have demonstrated for the first time a simple technique to effectively treat this under-recognized condition. They published their findings in the Journal of Invasive Cardiology on Dec. 15.
Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to their cancer diagnosis, according to a report published online in Blood. The study compared this group with similar adults who do not have cancer during the same period. Lung and colon cancers, as well as advanced-staged cancers, appear to be most strongly associated with an elevated risk of heart attack and stroke caused by blood clots in the arteries.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Tens of thousands of people across North Carolina are at high risk of developing cardiovascular disease that had not been identified previously, according to a new study published in Journal of the American Medical Informatics Association. The study team, composed of researchers at the University of North Carolina (UNC) School of Medicine and the UNC Gillings School of Global Public Health, created a statewide network of healthcare professionals in urban, suburban, and rural areas who work in small primary care practices and used existing electronic health records to identify at-risk individuals. Primary care doctors across the state then used this analysis to proactively engage patients to reduce their risk.
CathWorks announced that its FFRangio System received U.S. Food and Drug Administration (FDA) 510(k) clearance. The FFRangio system demonstrated accuracy versus the invasive fraction flow reserve (FFR) wire in a blinded comparative study, FAST-FFR. The results of the FAST-FFR pivotal study were used to establish substantial equivalence of the FFRangio system.
John Carroll, M.D., FACC, FSCAI, director of interventional cardiology at the Cardiac and Vascular Center at the ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Andreas Brieke, M.D., director of mechanical circulatory support, heart failure physician and site principal ...
Cardiva Medical Inc. announced the company has received premarket approval (PMA) from the U.S. Food and Drug Administration (FDA) for the Vascade MVP Venous Vascular Closure System. Vascade MVP is the first and only vascular closure system, according to Cardiva, designed and labeled specifically for multi-site venous closure – for 6-12 French inner diameter sheaths. This access site approach and size range is the standard in electrophysiology procedures such as cardiac ablation and left atrial appendage closure.
December 20, 2018 — The U.S. Food and Drug Administration (FDA) has warned Genetech Inc. and its president, Edwin N ...